InvestSMART

Biome Australia Limited (ASX:BIO)

ALERT: Price-sensitive ASX Announcement for BIO
Current share price for BIO : $0.270 -0.245 (-47.57%)+
Release
3 Sep 2025 8:39AM
Price at Release
$0.515
Full Release
download
Summary
Biome Australia Limited, a company specializing in microbiome health, announced its financial guidance for the first quarter of the fiscal year 2026, expecting sales revenue to exceed $5.5 million. This marks a new record, surpassing the previous quarter's revenue of $5.0 million. Established in 2018, Biome develops and markets evidence-based probiotics and complementary medicines, collaborating with global leaders in microbiome research. Their flagship products, including Activated Probiotics®, are designed to support health challenges and are backed by rigorous clinical trials.
Key Points
  • Biome Australia Limited expects Q1 FY26 sales revenue to surpass $5.5 million.
  • This revenue will set a new quarterly record, exceeding the previous $5.0 million in Q4 FY25.
  • Biome Australia is a microbiome health company focused on innovative biotherapeutics and complementary medicines.
  • The company partners with leading microbiome research organizations to produce unique probiotic products.
  • Biome's products, like Activated Probiotics®, are supported by clinical research and aim to improve various health outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.